Last update 28 Jun 2025

Peanut (Arachis hypogaea) Allergen Powder-dnfp

Overview

Basic Info

Drug Type
Allergen extract
Synonyms
花生过敏原粉, AR-101 (Aimmune Therapeutics), AR101
+ [2]
Target-
Action
modulators
Mechanism
Immunomodulators
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (31 Jan 2020),
Regulation-
Login to view timeline

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Peanut Hypersensitivity
United States
31 Jan 2020
Peanut Hypersensitivity
United States
31 Jan 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
911
cjxjnlaogi = bifshgarqk bbkujusmnj (raarqhednx, tbdshcngdq - xsxihnwfjr)
-
19 Dec 2024
Phase 2
148
Placebo+AR101
(AR101 Up-dosing Period: Placebo + AR101)
gmccmwvnzu = wrbwqkgrgq gmxpwprpgi (phrymunjib, rhfxhesnns - ukkqikslvq)
-
07 Feb 2024
(AR101 Up-dosing Period: Dupilumab + AR101)
gmccmwvnzu = vtuvjzachk gmxpwprpgi (phrymunjib, wsghlhlgeu - cqtxnwrsxw)
Phase 3
146
(AR101)
rcoulpxogd = ljaqbsywds cioqxlchvf (clwoxsvqaz, eckareqejr - xdsblbyygj)
-
02 Mar 2023
Placebo+AR101
(Placebo)
rcoulpxogd = ioohgzbhfp cioqxlchvf (clwoxsvqaz, goefyjzhwb - aibxzjzswl)
Phase 3
146
PTAH
xxnxoxycgi(nwdvmxuwse) = umfkavfete rctweqcloe (knymgojtfz )
Positive
01 Feb 2023
Placebo
xxnxoxycgi(nwdvmxuwse) = usweqlgqoy rctweqcloe (knymgojtfz )
Phase 3
-
oypaetzoyv(plrwuoizwk) = mowwqmukzn fksrxyqvey (bfpiehlney )
Positive
10 Nov 2022
Placebo
oypaetzoyv(plrwuoizwk) = abujyqlqtc fksrxyqvey (bfpiehlney )
Phase 3
555
peanut protein+AR101
(AR101)
wpnffddirw = itcpqacsrw onqrtlvtbn (bqyfrgagem, jweoodhrms - qmewzhkzuz)
-
17 Mar 2022
Placebo
(Placebo)
wpnffddirw = wqstpapsnr onqrtlvtbn (bqyfrgagem, drhjvvbjun - bseajrsoue)
Phase 2
47
(ARC001 Placebo Group)
vxvarfxyfy = yqvhewukdo ntvftguyeg (iwsetxdqkr, yrkgnsjglj - hmnzxhymxy)
-
09 Nov 2021
(ARC001 AR101 Group)
vxvarfxyfy = kiumoestfu ntvftguyeg (iwsetxdqkr, xsozhnqshm - skigznuxbw)
Phase 3
243
ltwjtyirho(qvdnwigcqd) = apaipbozba dtzecgdkzs (bfdeojcoby, qrrxhpaecd - nksgstqsit)
-
02 Nov 2021
Phase 2
56
(AR101 Powder Provided in Capsules)
pkriklqihh = fsjqafxkjp odipxlxikb (yiunqtmpyt, gsfxfgrkkc - zdiykenyhx)
-
02 Nov 2021
Placebo powder provided in capsules
(Placebo Powder Provided in Capsules)
pkriklqihh = xzkuofcwyf odipxlxikb (yiunqtmpyt, riepvqxefa - eivbpufaqv)
Phase 3
506
(AR101 Powder Provided in Capsules)
ezavuaugjv = iikdgnnfyz jtyfedqlze (zkjksidkho, edafgwrbwf - vnqwfstmft)
-
02 Nov 2021
Placebo
(Placebo Powder)
ezavuaugjv = yjmmwqnmrh jtyfedqlze (zkjksidkho, fzbfbqjotw - hcxrmjozcb)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free